{"database": "lobbying", "table": "lobbying_activities", "rows": [[2681020, "6c003377-d233-4902-8737-f21fd1db5463", "Q3", "TODD STRATEGY GROUP", 401103321, "ALKERMES, INC.", 2021, "third_quarter", "PHA", "Prescription drug pricing.", "HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2021-10-15T08:06:34.127000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2681020"], "units": {}, "query_ms": 0.38558198139071465, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}